Author: Celltrion Inc.

Posted Date:

April 21, 2026

Celltrion to present seven abstracts in inflammatory bowel disease (IBD) at 2026 Digestive Disease Week® (DDW)

Celltrion Inc.

April 21, 2026
Celltrion announces U.S. availability of AVTOZMA® (tocilizumab-anoh) subcutaneous (SC) formulation

Celltrion Inc.

March 16, 2026